NEW YORK and MISSISSAUGA, Ontario, July 18, 2011 /PRNewswire/ —
CardioGenics Holdings Inc. (CGNH.OB) announced today that their
July 12th RetailInvestorConferences.com presentation is available
for on-demand viewing at the RetailInvestorConferences website.
The presentation will be available 24/7 for 90 days. Investors
may download shareholder materials from the “virtual trade booth”
for the next three weeks.
About CardioGenics Holdings Inc.
Through its operating subsidiaries, the Company develops
ultra-sensitive analyzers and other products targeting the
immunoassay segment of the Point-Of-Care IVD testing market. It has
developed the QL Care™ Analyzer, a proprietary and
ultra-sensitive Point-Of-Care immuno-analyzer, which will run a
number of diagnostic tests under development, the first of which
will be a series of cardiovascular diagnostic tests. As part of its
core proprietary technology, the Company has also developed a
proprietary method for silver coating paramagnetic microspheres (a
fundamental platform component of immunoassay equipment), which
improve instrument sensitivity to light. The Company’s proprietary
microspheres technology and SAVAsphere™ magnetic beads are
developed and marketed through the Company’s Luxspheres subsidiary.
The Company’s principal offices are located in Mississauga,
Ontario, Canada. For more information please visit www.cardiogenics.com and www.luxspheres.com.